(WRB) W. R. Berkley - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0844231029
Commercial Insurance, Reinsurance, Excess Lines, Specialty Products
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.63% |
| Yield on Cost 5y | 7.09% |
| Yield CAGR 5y | 36.67% |
| Payout Consistency | 87.9% |
| Payout Ratio | 43.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.1% |
| Value at Risk 5%th | 34.9% |
| Relative Tail Risk | -4.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.87 |
| Alpha | 16.97 |
| CAGR/Max DD | 0.64 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.441 |
| Beta | 0.237 |
| Beta Downside | 0.157 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.42% |
| Mean DD | 7.26% |
| Median DD | 5.71% |
Description: WRB W. R. Berkley December 17, 2025
W. R. Berkley Corp. (NYSE:WRB) is a global commercial-line insurer organized into two operating segments: Insurance, which underwrites a broad mix of admitted and excess-surplus lines-including casualty, property, specialty, cyber, and personal-lines products-and Reinsurance & Monoline Excess, which provides treaty and facultative reinsurance solutions across property-casualty and niche turnkey coverages.
Key metrics as of the latest filing (Q3 2024) show net written premiums of $7.2 billion, a combined ratio of 93.5 % (indicating underwriting profitability), and a return on equity (ROE) of 12.8 %-both above the industry median of roughly 90 % combined ratio and 10 % ROE. The segment’s performance is sensitive to macro-economic drivers such as U.S. commercial construction activity, corporate litigation trends, and the frequency of cyber events, which have been rising at an estimated 8 % CAGR over the past five years.
For a deeper dive into WRB’s valuation assumptions and how its risk-adjusted return compares to peers, you may find it useful to explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (1.91b TTM) > 0 and > 6% of Revenue (6% = 879.2m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -0.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.07% (prev 240.5%; Δ -226.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 3.40b > Net Income 1.91b (YES >=105%, WARN >=100%) |
| Net Debt (435.8m) to EBITDA (2.53b) ratio: 0.17 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.08 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (400.2m) change vs 12m ago -0.40% (target <= -2.0% for YES) |
| Gross Margin 20.98% (prev 22.72%; Δ -1.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 34.86% (prev 32.69%; Δ 2.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 14.83 (EBITDA TTM 2.53b / Interest Expense TTM 127.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.00
| (A) 0.05 = (Total Current Assets 2.73b - Total Current Liabilities 668.7m) / Total Assets 43.72b |
| (B) 0.30 = Retained Earnings (Balance) 13.31b / Total Assets 43.72b |
| (C) 0.04 = EBIT TTM 1.88b / Avg Total Assets 42.04b |
| (D) 0.38 = Book Value of Equity 12.96b / Total Liabilities 33.91b |
| Total Rating: 2.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.17
| 1. Piotroski 6.0pt |
| 2. FCF Yield 12.43% |
| 3. FCF Margin 22.72% |
| 4. Debt/Equity 0.29 |
| 5. Debt/Ebitda 0.17 |
| 6. ROIC - WACC (= 6.16)% |
| 7. RoE 20.94% |
| 8. Rev. Trend 95.18% |
| 9. EPS Trend -0.44% |
What is the price of WRB shares?
As of December 23, 2025, the stock is trading at USD 70.22 with a total of 3,282,779 shares traded.
Over the past week, the price has changed by +1.62%, over one month by -7.98%, over three months by -2.82% and over the past year by +23.43%.
Over the past week, the price has changed by +1.62%, over one month by -7.98%, over three months by -2.82% and over the past year by +23.43%.
Is WRB a buy, sell or hold?
W. R. Berkley has received a consensus analysts rating of 3.56.
Therefor, it is recommend to hold WRB.
- Strong Buy: 5
- Buy: 1
- Hold: 8
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the WRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 72.9 | 3.9% |
| Analysts Target Price | 72.9 | 3.9% |
| ValueRay Target Price | 81.4 | 15.9% |
WRB Fundamental Data Overview December 22, 2025
Market Cap USD = 26.36b (26.36b USD * 1.0 USD.USD)
P/E Trailing = 14.5735
P/E Forward = 14.5985
P/S = 1.799
P/B = 2.6903
P/EG = 10.4316
Beta = 0.375
Revenue TTM = 14.65b USD
EBIT TTM = 1.88b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 24.5m USD (from shortTermDebt, two quarters ago)
Debt = 2.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 435.8m USD (from netDebt column, last quarter)
Enterprise Value = 26.80b USD (26.36b + Debt 2.84b - CCE 2.40b)
Interest Coverage Ratio = 14.83 (Ebit TTM 1.88b / Interest Expense TTM 127.0m)
FCF Yield = 12.43% (FCF TTM 3.33b / Enterprise Value 26.80b)
FCF Margin = 22.72% (FCF TTM 3.33b / Revenue TTM 14.65b)
Net Margin = 13.01% (Net Income TTM 1.91b / Revenue TTM 14.65b)
Gross Margin = 20.98% ((Revenue TTM 14.65b - Cost of Revenue TTM 11.58b) / Revenue TTM)
Gross Margin QoQ = 18.23% (prev 18.42%)
Tobins Q-Ratio = 0.61 (Enterprise Value 26.80b / Total Assets 43.72b)
Interest Expense / Debt = 1.12% (Interest Expense 31.8m / Debt 2.84b)
Taxrate = 21.01% (136.1m / 648.1m)
NOPAT = 1.49b (EBIT 1.88b * (1 - 21.01%))
Current Ratio = 4.08 (Total Current Assets 2.73b / Total Current Liabilities 668.7m)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.80b)
Debt / EBITDA = 0.17 (Net Debt 435.8m / EBITDA 2.53b)
Debt / FCF = 0.13 (Net Debt 435.8m / FCF TTM 3.33b)
Total Stockholder Equity = 9.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.36% (Net Income 1.91b / Total Assets 43.72b)
RoE = 20.94% (Net Income TTM 1.91b / Total Stockholder Equity 9.10b)
RoCE = 15.78% (EBIT 1.88b / Capital Employed (Equity 9.10b + L.T.Debt 2.84b))
RoIC = 12.46% (NOPAT 1.49b / Invested Capital 11.94b)
WACC = 6.31% (E(26.36b)/V(29.20b) * Re(6.89%) + D(2.84b)/V(29.20b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 6.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 80.04% ; FCFE base≈3.38b ; Y1≈3.85b ; Y5≈5.27b
Fair Price DCF = 240.1 (DCF Value 91.23b / Shares Outstanding 380.0m; 5y FCF grow 15.94% → 3.0% )
EPS Correlation: -0.44 | EPS CAGR: 2.03% | SUE: 0.63 | # QB: 0
Revenue Correlation: 95.18 | Revenue CAGR: 10.65% | SUE: 0.83 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.16 | Chg30d=-0.006 | Revisions Net=-2 | Analysts=15
EPS next Year (2026-12-31): EPS=4.63 | Chg30d=-0.013 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+5.4%
P/E Trailing = 14.5735
P/E Forward = 14.5985
P/S = 1.799
P/B = 2.6903
P/EG = 10.4316
Beta = 0.375
Revenue TTM = 14.65b USD
EBIT TTM = 1.88b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 24.5m USD (from shortTermDebt, two quarters ago)
Debt = 2.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 435.8m USD (from netDebt column, last quarter)
Enterprise Value = 26.80b USD (26.36b + Debt 2.84b - CCE 2.40b)
Interest Coverage Ratio = 14.83 (Ebit TTM 1.88b / Interest Expense TTM 127.0m)
FCF Yield = 12.43% (FCF TTM 3.33b / Enterprise Value 26.80b)
FCF Margin = 22.72% (FCF TTM 3.33b / Revenue TTM 14.65b)
Net Margin = 13.01% (Net Income TTM 1.91b / Revenue TTM 14.65b)
Gross Margin = 20.98% ((Revenue TTM 14.65b - Cost of Revenue TTM 11.58b) / Revenue TTM)
Gross Margin QoQ = 18.23% (prev 18.42%)
Tobins Q-Ratio = 0.61 (Enterprise Value 26.80b / Total Assets 43.72b)
Interest Expense / Debt = 1.12% (Interest Expense 31.8m / Debt 2.84b)
Taxrate = 21.01% (136.1m / 648.1m)
NOPAT = 1.49b (EBIT 1.88b * (1 - 21.01%))
Current Ratio = 4.08 (Total Current Assets 2.73b / Total Current Liabilities 668.7m)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.80b)
Debt / EBITDA = 0.17 (Net Debt 435.8m / EBITDA 2.53b)
Debt / FCF = 0.13 (Net Debt 435.8m / FCF TTM 3.33b)
Total Stockholder Equity = 9.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.36% (Net Income 1.91b / Total Assets 43.72b)
RoE = 20.94% (Net Income TTM 1.91b / Total Stockholder Equity 9.10b)
RoCE = 15.78% (EBIT 1.88b / Capital Employed (Equity 9.10b + L.T.Debt 2.84b))
RoIC = 12.46% (NOPAT 1.49b / Invested Capital 11.94b)
WACC = 6.31% (E(26.36b)/V(29.20b) * Re(6.89%) + D(2.84b)/V(29.20b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 6.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 80.04% ; FCFE base≈3.38b ; Y1≈3.85b ; Y5≈5.27b
Fair Price DCF = 240.1 (DCF Value 91.23b / Shares Outstanding 380.0m; 5y FCF grow 15.94% → 3.0% )
EPS Correlation: -0.44 | EPS CAGR: 2.03% | SUE: 0.63 | # QB: 0
Revenue Correlation: 95.18 | Revenue CAGR: 10.65% | SUE: 0.83 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.16 | Chg30d=-0.006 | Revisions Net=-2 | Analysts=15
EPS next Year (2026-12-31): EPS=4.63 | Chg30d=-0.013 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+5.4%
Additional Sources for WRB Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle